Hypertension and diabetes are significantly associated with insulin resistance (IR), which could affect the vasodilatory capacity and microcirculation. The aim of the study was to verify whether IR is associated with a reduced microvascular blood flow in normoglycemic mild hypertensives.
Impaired insulin sensitivity, which might be considered the key component of the metabolic syndrome, represents a wide and increasing health care problem exacerbating the risk of cardiovascular diseases. 1, 2 Insulin resistance (IR), clinically defined by a reduced ability of insulin to stimulate glucose uptake into skeletal muscle, is significantly associated with hypertension in both lean and obese patients. 3, 4 Interestingly, the reduced arterial vasodilating properties observed in hypertensives have been proposed as the hemodynamic determinant of this metabolic disorder 4 in both hypertensives and normotensives at risk of hypertension.
Several authors demonstrated that an exaggerated pulsatile component of blood pressure (BP), as a manifestation of arterial stiffness, is significantly associated with a reduced wave reflection 5 and to vascular damage in large and small arterial sites, such as carotid atherosclerosis and cerebral white matters. 6, 7 Previously, we demonstrated that mild hypertensives with IR show an exaggerated pulse pressure stress reactivity, 8 and independently of diabetes, it is associated with impaired microvascular vasodilating stress response. 9 The findings suggest that IR might be related to some BP determinants and functional hemodynamic disorders in the peripheral tissues.
The aim of the study was to verify whether a functional or structural hemodynamic impairment on the microvascular front might be associated with impaired insulin sensitivity per se in normoglycemic mild hypertensives.
METHODS
Patients, enrolled at the Hypertension Clinic, underwent physical examinations, ECG, chest X-rays, and fasting blood chemistry to exclude secondary hypertension, hepatic or renal impairments and diabetes. Patients with a positive history of cerebral, coronary, and peripheral vascular diseases were excluded from the study. This was authorized by Eighty-four consecutive (men/women: 48/36; age: 44 ± 2 years) recently diagnosed grade-1 hypertensives(SBP = 146± 2/ DBP = 92 ± 1 mm Hg) (European Society of Hypertension/ European Society of Cardiology, 2007), who were not taking any antidysmetabolic agent, were admitted to the study that featured an open design consisting of (i) a 4-week run-in period during which the antihypertensive medication (monotherapy) was replaced by placebo; (ii) then, between 8.30 and 9.30 am subjects underwent repeated routine blood chemistry tests and (iii) ambulatory BP monitoring (ABPM) applying a sized cuff to the nondominant arm, and (iv) finally, on the following day, patients underwent a laboratory reactivity study. To avoid anxiety raised by a new medical examination, patients were invited to visit the laboratory beforehand so as to become familiar with the equipment.
Patients arrived in the laboratory after a 12-h fasting period. After 10 min of rest in supine position, heart rate (HR) and BP were taken, in triplicate, at both arms to exclude any difference and the values were averaged. Samples for routine blood chemistry were taken. In particular, fasting blood glucose (hexokinase method for plasma glucose: Gluco-Quant Glucose/HK; Roche Diagnostic-Hitaki Instruments, Mannheim, Germany) and the immunoreactive plasma insulin concentration (Insulin CT; CIS Biointernational, ORIS, Gif-sur-Yvette, France) were measured. The homeostasis model assessment (HOMA) index was calculated as a measure of IR 10 and the patients were assigned to the tertile groups, according to the HOMA index, IR-Low, IR-Medium and IR-High. Patients then underwent ABPM to evaluate the BP and HR circadian changes. BP and HR were automatically measured every 20 min. Waking and sleeping time were determined by diary card entries.
The following day, a cardiovascular reactivity study was performed between 9.00 and 10.30 am, following 20 min of acclimatization in a quiet temperature-controlled room (24 °C), with the patients in supine position. We posed a mental and a physical task: (i) the Color Word Stroop test, 5-min long, based on incongruent visual input, required the patients to recognize within a time limit what colored ink was used to print the name of an incongruous color word and (ii) the cold pressor test, 90-s long, consisted of immersion of the right foot up to the ankle in iced water (4 °C). Each task was preceded and followed by 10-min long of baseline-recovery phases. 11 SBP, mean blood pressure, DBP (mm Hg), and HR (bpm) were continuously monitored using the Ohmeda 2300 Finapres (Ohmeda Monitoring System, Englewood, CO) on the middle finger mid-phalanx of the nondominant hand, resting on a wrist-holder.
A Laser-Doppler flowmeter (Oxford Array, Oxford Optronics Laser Doppler, Oxford, UK) was employed to measure, noninvasively and continuously, the peripheral skin blood flow. By way of this technique, infrared laser light with a wavelength of 780 nm is conducted through optical fibers to the skin, where it penetrates to a depth of 1.0-1.5 mm, largely avoiding the deeper and underlying subcutaneous fat, and then it is partly reflected. This light, when backscattered by moving erythrocytes, undergoes a frequency shift proportional to the velocity and number of moving objects and is expressed in arbitrary units and referred to the skin blood perfusion. 12 We employed Laser-Doppler flowmetry because the technique, if utilized in a controlled environment, is reliable, easy to use, related to neuroadrenergic activity, 13 and, interestingly, to the deeper microcirculation of the muscle where the insulin-mediated glucose uptake occurs. 14 Two surface Laser-Doppler probes (Oxford Array, SP100; Oxford Optronics Laser Doppler, Oxford, UK), attached with double-side-adhesive tape, were used to continuously obtain the forehead (LDF) and hand (LDH) skin blood flow. The first probe was attached to the central area of the forehead where the skin blood flow is mainly ascribed to changes of the passive perfusion pressure. The second probe was placed on the hypothenar area of the nondominant hand, where there are more numerous and effective arteriolovenular anastomoses, under the control of the sympathetic thermoregulatory system. 12 In our laboratory, high reproducibility of both LDH and LDF measurements was found (coefficients of variation 6 and 8%, respectively).
Because cardiovascular reactivity in hypertensives is frequently characterized by a prolonged response time, 15 the total stress reactivity, including the mental and physical tasks, baseline and recovery phases, was calculated as the "area-under-the-curve" (AUC = value × time). AUC improves the one-dimensional "time-to-recovery" measure, because it controls for the steepness of the decline in the level of the physiological parameter, and it was shown to represent an excellent predictor of vascular damage. 11 After 10 min of rest, when the baseline cutaneous flow recovered, we measured, at the 30th and the 60th second, the hand reactive hyperemia following ischemia induced by inflating a pediatric arterial occlusion cuff placed around the wrist of the nondominant arm, up to 200 mm Hg for 5 min. These measures, analogous to the minimal forearm postischemic vascular resistance, 9,11 served as indices of hemodynamic microvascular endothelial damage and reduced flow reserve capacity. 16 Data were analyzed with the SPSS statistical package. Posthoc analysis by the Student-Newman-Keuls test was used to compare groups. A two-tailed P value <0.05 was considered statistically significant. Pearson correlation coefficient and stepwise multiple regression analyses were applied to analyze the association of the IR with skin blood flow. Values are shown as mean ± s.e.m. in the text and tables and as mean ± s.d. in the figures.
RESULTS
Three patients, continuing to take placebo, needed to undergo ABPM a second time after 3 days, due to an invalid number of measurements (<80%). The cardiovascular reactivity study did not need to be suspended in any patient. Two patients underwent blood chemistry tests again on the following day due to laboratory accidents.
In accordance with the study design, the IR index HOMA was progressively higher in IR-High than in IR-Medium and articles
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IR-Low patients ( Table 1) . Sex distribution, age and estimated history of hypertension, office systolic/diastolic BP, and HR were similar ( Table 1) .
Triglycerides (153 ± 17 vs. 146 ± 13 vs. 155 ± 10 mg/dl), total-cholesterol (221 ± 15 vs. 205 ± 9 vs. 209 ± 8 mg/dl), and LDL-cholesterol (148 ± 14 vs. 132 ± 7 vs. 138 ± 8 mg/dl) were similar. On the contrary, HDL-cholesterol was similar in IR-Low (46 ± 2 mg/dl) and IR-Medium (44 ± 2 mg/dl) but lower in IR-High (40 ± 1 mg/dl; P < 0.05) patients.
Body mass index was higher in IR-Medium and IR-High patients. As expected, immunoreactive plasma insulin (µU/l) was progressively higher among patients (IR-Low = 10.2 ± 0.4 vs. IR-Medium = 17.4 ± 0.4, P < 0.001; vs. IR-High = 29.7 ± 2.9, P < 0.001). Blood glucose (mg/dl), although within normoglycemic limits, was higher only in IR-High patients (IR-Low = 87 ± 1.3 vs. IR-Medium = 90 ± 2.5, P = 0.323, IR-High = 97 ± 2.2, P < 0.001 vs. IR-Low and P < 0.05 vs. IR-Medium) (Figure 1) .
ABPM showed no significant differences in systolic and diastolic BP and HR, either during the day or the night. The IR-High patients demonstrated a significantly reduced nighttime fall in systolic and diastolic BP and HR ( Table 2) .
During the cardiovascular reactivity study, baseline systolic/diastolic BP and HR did not differ among groups. LaserDoppler flowmetry demonstrated a similar baseline skin blood flow at the hand (LDH) and at the forehead (LDF) ( Table 3) .
When the hemodynamic total reactivity, computed by the "AUC, " was examined, systolic and diastolic BP and HR did not show any difference ( Table 3) . On the contrary, LaserDoppler flowmetry demonstrated that the forehead and the hand skin blood flows were lower in patients with the highest IR ( Table 3) .
Postischemic hyperemia, both at 30 s (IR-Low = 396.3 ± 38.1 vs. IR-Medium = 348.9 ± 23.9, P = 0.297; vs. IR-High = 289.6 ± 24.8 arbitrary units, P < 0.05) and 60 s (IR-Low = 353.1 ± 37.5 AUC, total reactivity calculated by "area under the curve" = value × time; DBP-AUC, diastolic blood pressure total reactivity; HR-AUC, heart rate total reactivity; IR-High, patients with higher insulin resistance; IR-Low, patients with lower insulin resistance; IR-Medium, patients with medium insulin resistance; LDF-AUC, forehead skin blood flow total reactivity, measured by Laser-Doppler flowmetry; LDH-AUC, hand skin blood flow total reactivity, measured by Laser-Doppler flowmetry; SBP-AUC, systolic blood pressure total reactivity. *P < 0.05 vs. IR-Low; **P < 0.01 vs. IR-Medium. (Figure 2a) . Furthermore, when the microvascular postischemic blood flow delta change were measured they were progressively impaired in IR-Medium and IR-High patients, both at 30 and 60 s (Figure 2b) .
Pearson correlations were computed to highlight the association between the HOMA index and microvascular reactivity, and Laser-Doppler changes during hyperemia. Because the distribution of the HOMA index, LDH-AUC, and LDF-AUC were skewed, a log transformation was adopted to yield a normal distribution of values. Office SBP and DBP values, age, estimated history of hypertension, BMI, blood glucose, hematocrit, and lipids were introduced into the equation to control for possible confounders. LDH-AUC was inversely and significantly associated with IR but LDF-AUC did not show any correlation (Figure 3a) . Postischemic LDH was inversely associated with the HOMA index both at 30 s and at 60 s during hyperemia (Figure 3b) .
Stepwise multiple regression analysis with the HOMA index as the dependent variable and age, history of hypertension, BMI, office, and baseline SBP/DBP and baseline LDH and LDF, as independent variables showed that only BMI (β = 0.336, P < 0.001), at the first step and LDH (β = −0.239, P < 0.05) at the second step, entered into the equation. When hemodynamic total reactivity and postischemic LDH measures as indices of microvascular damage were considered, only the LDH change at 60 s (β = −0.321, P < 0.01) at the first step, and the LDH-AUC (β = −0.296, P < 0.01) at the second step, entered into the equation. Altogether, the findings suggest that IR may be associated with microvascular functional and structural constrictive damage in mild hypertensives.
DISCUSSION
The findings highlighted that IR is associated with reduced microcirculatory flow both during functional demands and hyperemic postischemic response, as the hemodynamic index of structural damage in euglycemic recently diagnosed mild hypertensives.
Different studies, in fact, have shown that a combination of hypertension and IR is a condition that seriously increases the risk of cerebral and cardiovascular damage. 1, 6, 17 In our study, the IR-High group had a similar estimated history of hypertension, BP office values, daytime and nighttime ambulatory BP, as well as daytime-office BP differences. Also BP/HR reactivity showed no difference between groups. The findings confirm an equivalent hypertensive state and rule out the possibility that a white-coat phenomenon or cardiovascular reactivity could have affected the diagnosis of hypertension in patients with different IR. Moreover, the anthropometric and the metabolic features, confined within the limits constituting the metabolic syndrome, demonstrate that reduced insulin sensitivity per se may be associated with microcirculatory damage in mild hypertensive patients. The findings are in agreement with the evidence that mild hypertensives with type-2 diabetes show a higher vascular constriction 18, 19 during resting conditions and laboratory stimuli, and insulin-resistant patients have impaired functional vasodilatation. 4, 5 In fact, no difference was found in baseline BP, but, interestingly, during nighttime when central nervous system-derived adrenergic drive, BP, and cardiovascular variability are reduced, the BP and HR nighttime fall were reduced in IR-High patients. Interestingly, the sympathetic articles Microvascular Functions and Insulin Resistance nervous system drive may be induced by lifestyle factors such as a high carbohydrate and fat intake and low level of physical activity, by promoting higher insulin levels. In this regard, IR has previously been associated with enhanced hemodynamic stress response. 8, 19 This has been noted in healthy young adults and children with high insulin levels or IR, as well as in patients with a risk of hypertension. Thus, hemodynamic functional characteristics, related to centrally mediated sympathetic overdrive, 5, 8, 15 may precede the onset of both IR and hypertension 20 and exacerbate the consequences of the diseases.
A closer consideration of mechanisms underlying the hemodynamic reactivity may help us to understand how altered responses contribute to specific diseases. 21 In our study, the stress response to different laboratory stimuli was investigated, in standardized conditions, by measuring the "AUC. " 7, 11, 21 This measure was previously found to be related to vascular damage and impaired endothelium-mediated vasodilatation. Our findings show that the BP/HR reactivity did not differ, but the microvascular cutaneous flow during stress, both on the forehead and the hand, showed a reduced change in IR-High patients. Different authors have shown that the true capillary flow is reduced in diabetic patients, 16 and they manifest, as from the early stages of the disease, an impaired capillary vasomotion secondary to enhanced sympathetic nervous system drive. 13 Characteristically, the skin blood flow response was particularly reduced and prolonged when this was recorded at the hand, where there is an elevated neurogenic control of the microcirculation. 22 The inverse relationship between IR and vascular dilation response may, therefore, be explained by several additional mechanisms, including the facilitated insulin-mediated response of the vascular smooth musculature to vasoconstrictor agents and vascular smooth muscle cell proliferation. 23 The HOMA index was thus found to be predictive of an impaired hyperemic microcirculatory flow suggesting that IR per se may aggravate the microvascular vasoconstriction in hypertensives. Indeed, subjects with a risk of hypertension and established hypertensives have been repeatedly demonstrated to be affected by impaired postischemic peripheral blood flow and capillary rarefaction. 24 IR was found to be associated with thickening of the capillary basement membrane, a condition that can reduce the recruitment of capillaries during hyperemic states. On the other hand, microvascular alterations and their consequences justify the consideration of hypertension as a tissue disease featuring elevated oxidative stress, vulnerability to inflammatory stimuli, and a dramatic, early rarefaction of the microcirculation. 25 Thus, IR-High patients, independent of their hypertensive state and fasting blood glucose, showed impaired microcirculatory flow during neurogenic stimuli and reduced microvascular endothelium-mediated reactive hyperemia. These findings suggest that the microvascular impairment may be one of the consequences of a failing glucose-insulin metabolism. 16 Tissue metabolism and local microflow, in fact, are tightly coupled in such a way that flow adapts to the metabolic demands of the surrounding tissue. 26 An increased tone of the terminal arterioles may increase the precapillary resistance and, therefore, alter the transfer of solutes to the adjacent interstitial fluid compartment and capillary recruitment 18, 25 in the skeletal muscle. This may play a critical role in glucose uptake and modulation of peripheral vascular resistance. 27 Altogether, the findings suggest that IR might be an independent factor aggravating the functional peripheral vasoconstriction and the structural damage in the microcirculation, as well as impairing the flow reserve in other critical vascular beds such as the coronary arteries. 28 Interestingly, patients with reduced coronary reserve show also measures of impaired vasodilatation in the muscular and skin microcirculation. 9, 11, 14, 24 Several negative feedback mechanisms occur in the microvascular endothelium of patients affected by IR. They can induce an imbalance between endothelium-derived constricting and dilating factors, boosting the former and thus aggravating the effect of high BP. Moreover, interleukin-1 receptor antagonist, interleukin-6, and TNF-α show both delayed and sustained responses to mental stress, showing that the inflammatory state might be associated with the sympathetic reactivity. 29 Exaggerated microvascular reactivity, such as found in IR-High patients, may, therefore, contribute to enhance the endothelial injury and to accelerate the inflammation process, thus creating a vicious circle exacerbating microvascular and, later, macrovascular constrictive damage. 7, 9, 30 The study will be continued so as to highlight the pivotal link of IR and microvascular damage to the onset of arterial stiffness, increasing the number of very mild hypertensives and measuring the arterial compliance. Our findings suggest that a functional approach such as the one we used, employing affordable techniques able to explore the sympathetic drive regulating the microcirculation, may highlight the very early disturbances secondary to the reduced peripheral insulin sensitivity.
IR per se, particularly in hypertensives, may affect the microcirculatory properties, contribute to raise the vasoconstriction and worsen the hypertensive state. Then the functional perfusion of a large number of vital organs will be impaired by IR increasing the cerebro-and cardiovascular morbidity and mortality even in euglycemic patients with marginally increased arterial BP.
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